MIGROT 50mg Tablet 6s

Frequently asked questions

• Onset of action

  The amount of time required for this medicine to show its action is about 10 minutes after a subcutaneous administration and 30 minutes after an oral administration.

• Duration of Effect

  The time until which this medicine remains active in the body is not clinically established.

• Safe with Alchohol?

  Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

• Is it habit forming?

  No habit forming tendency has been reported.

• Usage in pregnancy?

  This medicine is not recommended for use in pregnant women unless necessary. Discuss all the risks and benefits with your doctor before taking this medicine.

• Usage while breast-feeding?

  This medicine is not recommended for use in breastfeeding women unless necessary. Discuss all the risks and benefits with your doctor before taking this medicine.

• Allergy

  This medicine is not recommended for use in patients with a known allergy to MIGROT 50mg Tablet 6s .

• Cardiovascular Disease

  This medicine is not recommended for use in patients with a known history of cardiovascular diseases due to the increased risk of worsening of the patient's condition.

• Uncontrolled hypertension

  This medicine is not recommended for use in patients with a history of uncontrolled hypertension due to the increased risk of very high blood pressure and hypertensive crisis.

• Peripheral vascular diseases

  This medicine is not recommended for use in patients with a known history of peripheral vascular diseases due to the increased risk of worsening of the patient's condition.

• Monoamine oxidase inhibitors (MAOI)

  This medicine is not recommended for use in patients taking monoamine oxidase inhibitors (MAOI) due to the increased risk of a life-threatening condition called Serotonin Syndrome. A time gap of at least 14 days should be maintained between stopping therapy with MAOIs and starting therapy with this medicine.

• Severe liver impairment

  This medicine is not recommended for use in patients with severe liver disease due to the increased risk of worsening of the patient's condition.

• Pregnancy

  This medicine is not recommended for use in pregnant women unless necessary. Discuss all the risks and benefits with your doctor before taking this medicine.

• Breast-feeding

  This medicine is not recommended for use in breastfeeding women unless necessary. Discuss all the risks and benefits with your doctor before taking this medicine.

• High cholesterol

  This medicine should be used with caution in patients with a known history of high cholesterol levels due to the increased risk of cardiovascular side effects.

• Liver diseases

  This medicine should be used with caution in patients with a known history of liver diseases. Appropriate dose adjustments should be made based on the clinical condition of the patient to avoid serious side effects.

• Seizure disorder

  This medicine should be used with caution in patients with a known history of seizure disorder due to the increased risk of worsening of the seizures.

• Wolff-Parkinson-White Syndrome

  This medicine is not recommended for use in patients with Wolff-Parkinson-White syndrome or arrhythmias due to the increased risk of life-threatening disturbances of the cardiac rhythm.

Take this medicine exactly as instructed by the doctor. Do not take larger amounts than prescribed. Seek emergency medical treatment in case of any severe side effects. Ensure that the course of treatment is completed. Do not stop the use of this medicine without consulting your doctor.

• Can be taken with or without food, as advised by your doctor
• To be taken as instructed by doctor
• May cause sleepiness

• webmd.com - Sumatriptan [Internet]. Available from: https://www.webmd.com/drugs/2/drug-7741/sumatriptan-oral/details [cited 27/7/2020].
• medlineplus.gov - Sumatriptan [Internet]. Available from: https://medlineplus.gov/druginfo/meds/a601116.html [cited 27/7/2020]. 2020